Andrew Marshall, PhD

Dr. Marshall is co-inventor of our novel STAR biomaterial, and has over 15 years of experience developing this technology and its applications for improving the performance of implantable medical devices.  He holds 25 issued and pending patents, and his work has been recognized by the awarding to Healionics of over $7M in competitive non-dilutive R&D grants from NIH and DOD, including $6M to advance our STARgraft technology for maintaining patency of synthetic blood vessels.

Dr. Marshall also serves on the Scientific Advisory Board for iSTAR Medical, Healionics’ Belgium-based ophthalmic device spinout.  He designed the biointegrating porous biomaterial used in iSTAR’s glaucoma drainage devices, including MINIject, a novel micro-invasive glaucoma surgery (MIGS) device with exceptional early clinical results.

Dr. Marshall has been recognized as one of 40 Under 40 influential leaders and innovators by Medical Devices & Diagnostics Industry magazine, and he was honored at the 2012 World Congress on Tissue Engineering & Regenerative Medicine as the recipient of the Innovation/Commercialization Award.

Dr. Marshall earned his PhD in Chemical Engineering from the University of Washington and has a BSE in Biomechanical Engineering from Stanford University.